screening

Articles

Precision care: supporting our patients starts with asking them what they want and need

Two weeks after receiving a brain tumour diagnosis, Martin was copied into an email from one of his healthcare team telling his GP that Martin was “understandably devastated by his diagnosis”. The…

Voices

How we turn lung cancer care into a European success story

Opportunities to make significant headway against cancer don’t come around very often. This year, an alignment of science and European cancer policy is opening such an opportunity in relation to lung cancer…

Voices

Liver patient advocates to Europe’s cancer community: can we talk?

Europe’s Beating Cancer plan is galvanising the cancer community behind efforts to tackle rising trends that are currently on course for an almost 25% rise in deaths from cancer across Europe by…

Articles

Liver cancer: how Europe can halt the rising death toll

When the cancer community in Europe talks of neglected cancers it usually means relatively rare or uncommon types, of which there are many. But conspicuous in the list are two digestive cancers…

Articles

Lung cancer screening: time to act on the evidence

“It’s extraordinary that screening for the biggest cancer killer is not available in most of Europe," says Anne Marie Baird, President of Lung Cancer Europe (LuCE). “Lung cancer causes more deaths in…

News

Study suggests tackling loneliness could help reduce cancer in middle-aged men

Loneliness among middle-aged men is associated with increased risks of developing cancer. The longitudinal Finnish study, published in the May issue of Psychiatry Research, additionally found mortality was higher among male cancer…

Articles

Prostate cancer: new leads for deterring progression

Future prospects for tackling aggressive prostate cancer emerged from two presentations at the American Association for Cancer Research Annual meeting, held virtually in mid-April. One identified how the risk of prostate cancer…

Articles

PSA population screening is back in favour: here’s why

Five years ago, the idea of national screening programmes for prostate cancer had gone cold. The benefits of PSA (prostate specific antigen) blood testing, introduced as a screening tool in the 1980s,…

Articles

Older, frail patients are still being let down by the regulators

Hans Wildiers is frustrated. “This drug is well-tolerated in older persons – this is a very frequent conclusion in publications. And it is often not a correct conclusion,” says the immediate past…

News

Study brings mass biparametric MRI screening for prostate cancer a step closer

Using biparametric (bp) magnetic resonance imaging (MRI) to screen for prostate cancer identified twice as many clinically significant cancers as standard prostate-specific antigen (PSA) tests. Moreover, the UK study, reported in JAMA…